HCC could be treated by adjusting the proportion of the Kupffer macrophage, the treatment of TACE could decrease the expression of CYP3A4 with HepG2 HCC cells (Alican et al., 2023). Here, CYP3A4 is linked to hepatocellular carcinoma.